Redhill Biopharma

- NASDAQ:RDHL
Last Updated 2021-09-20
  • Late Clinical-Stage Formulations of Existing Drugs
  • Locations

    • Ramat Gan Tel Aviv
  • Total Funding (USD)

    10.0 million
  • Industries

    Real Estate, Mobile Apps, Video Games, Internet
  • Security

    Type: ADR
    CUSIP: 757468103
    ISIN: US7574681034
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.